|
|
|
Volumn 74, Issue 1, 2003, Pages 97-99
|
|
Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN);Anderung der arzneimittel-richtlinien des bundesausschusses der ärzte und krankenkassen bezüglich atypischer neuroleptika. Stellungnahme der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLINICAL PRACTICE;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
PSYCHOTHERAPY;
REVIEW;
TREATMENT INDICATION;
ACUTE DISEASE;
ANTIPSYCHOTIC AGENTS;
GERMANY;
HEALTH POLICY;
HUMANS;
NATIONAL HEALTH PROGRAMS;
PRACTICE GUIDELINES;
SCHIZOPHRENIA;
|
|
EID: 0038626218
PISSN: 00282804
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
